Navigation Links
Tor/Forge Launches THE CURE, a Riveting Thriller in the Tradition of Michael Crichton, by the New York Times Bestselling Author of WIRED.
Date:9/17/2013

(PRWEB) September 17, 2013

Tor/Forge today announced the hardcover and eBook launch of THE CURE, by New York Times bestselling author, Douglas E. Richards. THE CURE provides an eye-opening look at the science of psychopathy within an explosive, roller-coaster-ride of a novel that will keep both thriller fans, and science fiction fans, reading deep into the night. "Richards is a tremendous new talent," said Stephen Coonts, author of seventeen New York Times bestselling thrillers. "THE CURE is an extraordinarily good novel that will keep you riveted . . . and thinking."

Psychopaths seem to be at epidemic levels, and new research indicates their brains differ from those of normals, possibly accounting for their absolute selfishness, ruthlessness, and lack of conscience. And while most aren’t the Hannibal Lecter type, even the seemingly benign psychopaths among us inevitably leave a trail of shattered lives in their wakes.

“What if you could invent a simple way to diagnose this condition?” said Richards. “Would society be justified in monitoring psychopaths? Even before they’ve committed any crimes? What if you found the cure for this condition? While answers to these questions may seem straightforward, the deeper you dig, the more unexpected complexities you find.”

In THE CURE, Erin Palmer suffers through a devastating encounter with a psychopath as a child. Now a grad student and scientist, she’s devoting her life to studying these monsters. When her research catches the attention of Hugh Raborn, a brilliant neuroscientist who claims to have isolated the genes responsible for psychopathic behavior, Erin realizes it may be possible to reverse this condition, restoring souls to psychopaths. But to do so, she’ll not only have to operate outside of the law, but violate her most cherished ethical principles.

When Erin learns Raborn harbors dark secrets, all hell breaks loose. Is he working for the good of society? Or is he intent on bringing humanity to its knees?

Douglas E. Richards has been widely praised for his ability to weave action, suspense, and science into riveting novels that brilliantly straddle the thriller and science fiction genres. With THE CURE, Richards has done it again, penning a novel that, according to #1 New York Times bestselling author, Douglas Preston, "Will keep you turning the pages all night long."

THE CURE, released on September 17th, is available wherever books are sold.

To request a review copy, for more information, or to schedule an interview with the author, please contact Karen Lovell at 646.307.5409 or karen.lovell(at)tor(dot)com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11058161.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Meso Scale Discovery Launches V-PLEX™ Multiplex Biomarker Immunoassays
2. SPIE Launches New Symposium to Foster Dual-Use Sensor Technologies
3. CPUsage Launches Massive Scale Cloud Computing Platform at TechCrunch Disrupt
4. Salimetrics Launches a Better Salivary IL-6 ELISA/EIA Kit
5. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
6. University of Houston launches first nanotech company
7. Sciedu Press Launches New Journal for Management and Orgnaization Studies
8. BellBrook Labs Launches New Turn Key Methyltransferase Assay Kit for Oncogenic Histone Methyltransferase EZH2
9. Real Time Genomics Launches Two New Products in Human Disease Research
10. Clinovo Launches New Version of CDISC® Express, its CDISC SDTM Mapping Tool
11. ACRES Launches Global Clinical Research Network Technology Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... for phase I clinical trials comes to Tampa, San Francisco and Boston in ... professionals representing FDA regulated organizations such as Pfizer Inc., Teva Pharmaceuticals, Advaxis, Inc., ...
(Date:4/26/2017)... Va. (PRWEB) , ... April 26, 2017 , ... ... make headlines and drive high-level conversations among healthcare industry stakeholders, the discussion surrounding ... Environment – taking place May 15-18, 2017 in Los Angeles, Calif. Hosted by ...
(Date:4/25/2017)... ... April 25, 2017 , ... L3 Clinical Trials, the ... company is now a certified iMedNet eClinical and Electronic Data Capture software designer ... clinical research team to build, customize and manage clinical trial data capture and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Leaders of Quorum Review IRB and ... multiple sessions at this week’s Association of Clinical Research Professionals (ACRP) 2017 Meeting ... clinical research. , "We are excited to present subject matter expertise on topics that ...
Breaking Biology Technology:
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):